How do I know if my company's sales process is structured enough to be attractive to a potential PE buyer?

Why PE buyers care more about the process than the number

A buyer underwriting a $5M-$15M ARR company isn't just pricing current revenue. They're pricing the probability that revenue keeps growing under new ownership, with a new management layer, without the founder in every deal. That's a bet on repeatability, and repeatability shows up as process artifacts, not pitch-deck claims. Bain's private equity research has flagged commercial due diligence — specifically pipeline durability and sales process maturity — as one of the most common sources of post-close value erosion when it's skipped or rushed during diligence.

In practice, diligence teams run a checklist. They want to see a CRM (not spreadsheets) with real usage, a documented sales process with defined stages, historical pipeline data going back at least a year, and evidence that revenue isn't tied to one person's Rolodex. Companies that pass these checks cleanly tend to close faster and avoid valuation haircuts tied to "key person risk" or "sales infrastructure gaps" — language that regularly appears in quality-of-earnings reports.

The five-point self-audit

Run this before a buyer does. Each item below is binary: you either have evidence or you don't.

CRM adoption, not just CRM existence. A tool nobody updates is worse than no tool, because it signals a documentation gap a buyer will have to solve themselves. Check login frequency and whether deal stages get updated without reminders. If adoption is sub-50%, that's a red flag, not a yellow one.

Documented stages with exit criteria. "Discovery, Demo, Proposal, Close" isn't a process — it's a label. A buyer wants to see what moves a deal from one stage to the next (a signed mutual action plan, a technical validation call, a budget confirmation) and whether reps actually follow it.

At least 12 months of pipeline history. Win rates, cycle length, and conversion by stage all require a trailing data set. If your CRM was implemented eight months ago, you don't have this yet, and that's a timing problem worth solving before you go to market, not during diligence.

Revenue concentration away from the founder. If the founder personally closes or touches most deals, that's labeled key person risk in every QofE report and it directly depresses multiple. Buyers want to see reps or an AE team generating revenue independent of the founder's calendar.

A named sales leader who isn't the CEO. Even fractional counts, as long as the role is distinct from ownership and has real authority over quota, hiring, and pipeline review cadence.

What happens if you fail the audit

Nothing immediate — but expect one of two outcomes at the table. Either the multiple gets adjusted downward to price in the remediation work, or the deal includes an earnout tied to building exactly the infrastructure described above, which means you're doing the work anyway, just under someone else's timeline and with your payout at stake. Neither is catastrophic, but both are avoidable with 6-12 months of lead time.

Where SalesARC fits

This is a documentation and CRM-adoption problem before it's a financial one. SalesARC Playbook (from $999 one-time for the Basic tier) builds the documented process with stage definitions a diligence team expects to see, and SalesARC Perform (from $2,499/month) provides fractional sales leadership to run the cadence that proves the process is actually used, not just written down. Neither replaces a real QofE engagement, but both reduce the gap a buyer finds. See /product/playbook.